We are 3,5-DimEthylpyrrole-2,4-Dicarboxylic Acid 2-t-Butyl Ester-4-Ethyl Ester CAS:86770-31-2 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name: 3,5-DimEthylpyrrole-2,4-Dicarboxylic Acid 2-t-Butyl Ester-4-Ethyl Ester
2-O-tert-butyl 4-O-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate
Molecular Formula: C14H21NO4
Molecular Weight: 267.32100
Physical and Chemical Properties:
Density: 1.103 g/cm3
Boiling point: 386.8ºC at 760 mmHg
Melting point: /
Refractive index: 1.509
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Sunitinib Malate CAS:341031-54-7
Intermediates of Sunitinib CAS:557795-19-4
Related News: The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels.1-fenil-2- [3- (4,4,5,5-tetrametil-1,3,2-dioxaborolan-2-il) fenil] bencimidazol CAS:952514-86-2 The second is known as the excipient, which is the inactive substance that serves as the vehicle for the API itself.875444-08-9 The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.65799-47-5 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market.